March 2016


In this Supplement

Advancing Care From the Arch to the Iliacs

A look at innovation and clinical studies advancing endovascular aortic repair.



Download a PDF of this supplement

Evolution of Endovascular Management of Common Iliac Artery Aneurysms

With newer-generation devices and increasing operator experience, there is potential to broaden the scope of EVAR for iliac artery aneurysms.

By Tiffany Wu, MD; and Jason T. Lee, MD

Global Perspectives on the Value of Internal Iliac Artery Preservation

Expert vascular surgeons share international experiences with iliac branch devices and the value of preservation.

By Michael Neale, MM (USyd), MBBS (UNSW), FRACS; Jorge Fernández Noya, MD; and Darren B. Schneider, MD

Initial Experience With the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis

An overview of device characteristics and case reports from the first three worldwide implantation procedures.

By Gustavo S. Oderich, MD; and Pierre Galvagni Silveira, MD, PhD

Long-Term Data Supporting the Conformable GORE® TAG® Thoracic Endoprosthesis in DTA Pathologies

An overview of the recent data that confirm positive results when using this device to treat both acute and chronic conditions of the descending thoracic aorta.

By Mark A. Farber, MD; Richard Cambria, MD; and William Jordan, MD

Chronic Type B Dissection: Rules of Engagement for TEVAR

Endovascular solutions in the management of chronic type B dissections.

By Ibrahim Sultan, MD; Nimesh D. Desai, MD, PhD; and Joseph E. Bavaria, MD

Understanding the Predictors of Aneurysmal Degeneration in Type B Dissection

A case example illustrating when early endovascular intervention may provide the best outcome.

By Dittmar Böckler, MD, PhD; Marius Ante; and Moritz S. Bischoff, MD

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.